Schedule 13G ownership disclosure
PLIANT THERAPEUTICS INC
Common Stock · CUSIP: 729139105
Event date: 2025-06-30
- Filing-level shares
- 3,002,348
- Percent of class
- 4.89%
- The Vanguard Group
Shares: 3,002,348 · Class: 4.89%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000932471-25-000999
- Form type
- SCHEDULE 13G/A
- Filer
- PLIANT THERAPEUTICS, INC.
- CIK
- CIK 1746473
- Filed
- Jul 29, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership